Epidemiology of SARS-CoV-2
- PMID: 33034020
- PMCID: PMC7543961
- DOI: 10.1007/s15010-020-01531-3
Epidemiology of SARS-CoV-2
Abstract
Purpose: SARS-CoV-2 is a recently emerged ß-coronavirus. Here we present the current knowledge on its epidemiologic features.
Methods: Non-systematic review.
Results: SARS-CoV-2 replicates in the upper and lower respiratory tract. It is mainly transmitted by droplets and aerosols from asymptomatic and symptomatic infected subjects. The consensus estimate for the basis reproduction number (R0) is between 2 and 3, and the median incubation period is 5.7 (range 2-14) days. Similar to SARS and MERS, superspreading events have been reported, the dispersion parameter (kappa) is estimated at 0.1. Most infections are uncomplicated, and 5-10% of patients are hospitalized, mainly due to pneumonia with severe inflammation. Complications are respiratory and multiorgan failure; risk factors for complicated disease are higher age, hypertension, diabetes, chronic cardiovascular, chronic pulmonary disease and immunodeficiency. Nosocomial and infections in medical personnel have been reported. Drastic reductions of social contacts have been implemented in many countries with outbreaks of SARS-CoV-2, leading to rapid reductions. Most interventions have used bundles, but which of the measures have been more or less effective is still unknown. The current estimate for the infection's fatality rate is 0.5-1%. Using current models of age-dependent infection fatality rates, upper and lower limits for the attack rate in Germany can be estimated between 0.4 and 1.6%, lower than in most European countries.
Conclusions: Despite a rapid worldwide spread, attack rates have been low in most regions, demonstrating the efficacy of control measures.
Keywords: Basic reproduction number; COVID-19; Epidemiology; Incubation period; Infection fatality risk; Mortality; Pandemic; SARS-CoV-2.
Conflict of interest statement
None reported.
Figures



Similar articles
-
[Epidemiology of SARS-CoV-2/COVID-19].Gastroenterologe. 2020;15(6):443-451. doi: 10.1007/s11377-020-00479-y. Epub 2020 Oct 29. Gastroenterologe. 2020. PMID: 33144889 Free PMC article. Review. German.
-
[Epidemiology of SARS-CoV-2 infection and COVID-19].Internist (Berl). 2020 Aug;61(8):782-788. doi: 10.1007/s00108-020-00834-9. Internist (Berl). 2020. PMID: 32548652 Free PMC article. Review. German.
-
[SARS-CoV-2/COVID-19-epidemiology and prevention].Nephrologe. 2021;16(1):3-9. doi: 10.1007/s11560-020-00472-0. Epub 2020 Dec 15. Nephrologe. 2021. PMID: 33343742 Free PMC article. Review. German.
-
Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.Lancet Infect Dis. 2020 Oct;20(10):1141-1150. doi: 10.1016/S1473-3099(20)30471-0. Epub 2020 Jun 17. Lancet Infect Dis. 2020. PMID: 32562601 Free PMC article.
-
Measuring Basic Reproduction Number to Assess Effects of Nonpharmaceutical Interventions on Nosocomial SARS-CoV-2 Transmission.Emerg Infect Dis. 2022 Jul;28(7):1345-1354. doi: 10.3201/eid2807.212339. Epub 2022 May 17. Emerg Infect Dis. 2022. PMID: 35580960 Free PMC article.
Cited by
-
Relationship between nosocomial infections and coronavirus disease 2019 in the neurosurgery unit: clinical characteristics and outcomes from a Chinese Tertiary-Care Hospital.BMC Infect Dis. 2022 Nov 11;22(1):836. doi: 10.1186/s12879-022-07845-x. BMC Infect Dis. 2022. PMID: 36368929 Free PMC article.
-
Genomic and Epidemiological Features of COVID-19 in the Novosibirsk Region during the Beginning of the Pandemic.Viruses. 2022 Sep 14;14(9):2036. doi: 10.3390/v14092036. Viruses. 2022. PMID: 36146842 Free PMC article.
-
COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review.World J Virol. 2021 Nov 25;10(6):312-325. doi: 10.5501/wjv.v10.i6.312. World J Virol. 2021. PMID: 34909405 Free PMC article. Review.
-
COVID-19 severity: does the genetic landscape of rare variants matter?Front Genet. 2023 Jun 29;14:1152768. doi: 10.3389/fgene.2023.1152768. eCollection 2023. Front Genet. 2023. PMID: 37456666 Free PMC article.
-
Booster Vaccination Decreases 28-Day All-Cause Mortality of the Elderly Hospitalized Due to SARS-CoV-2 Delta Variant.Vaccines (Basel). 2022 Jun 21;10(7):986. doi: 10.3390/vaccines10070986. Vaccines (Basel). 2022. PMID: 35891151 Free PMC article.
References
-
- WHO. Coronavirus Disease (COVID-2019) Situation Report, 25.08.2020. Geneva. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio.... Accessed 25.08.2020.
-
- RKI. TäglicherLagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19) 25.08.2020 – AKTUALISIERTER STAND FÜR DEUTSCHLAND. Berlin: Robert-Koch-Institut2020 25.08.2020.
-
- 3–5
-
- WHO. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Geneva: WHO2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous